This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $100,636.46, is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and B vaccine, at a ceiling value of $1,481.68. The contract has a firm fixed price pricing type and an ultimate completion date of March 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor to the U.S. federal government. The $2,704.32 firm fixed-price contract is for the supply of TWINRIX VACCINE SYRINGES, a hepatitis A and hepatitis B combination vaccine, with a completion date of September 4, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B combination vaccine, with a ceiling value of $5,728.81. The contract is a firm fixed-price delivery order with a performance period extending to June 13, 2025. This contract is not designated as a set-aside, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,818.87 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX VACCINE SYRINGEml, a hepatitis A and hepatitis B vaccine, with a ceiling value of $1,078.23 and a period of performance through April 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the TWINRIX vaccine, a combined hepatitis A and hepatitis B vaccine, with a ceiling value of $7,895.37. The contract is a Firm Fixed Price (FFP) delivery order with a completion date of May 29, 2025. The contract is not set aside and is open to full and open competition. As...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $20,282.40 firm fixed-price contract is for the delivery of TWINRIX VACCINE SYRINGE ML, a combination vaccine used to prevent hepatitis A and hepatitis B. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,031.40 firm fixed-price contract is for the delivery of the TWINRIX VACCINE SYRINGE, a vaccine product, with a completion date of June 18, 2025. The contract is not set-aside and was awarded on June 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,147.22 firm fixed-price contract is for the supply of TWINRIX VACCINE SYRINGEML, a vaccine product. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...